PLETAL

LOE Approaching

cilostazol

NDAORALTABLET
Approved
Jan 1999
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT04452929N/AUnknown

The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients

Started Jul 2020
72 enrolled
MigraineMigraine Without AuraMigraine With Aura
NCT04407312Phase 4Unknown

Cilostazol and Endothelial Progenitor Cell

Started Jan 2016
60 enrolled
Myocardial Infarction, Acute
NCT02554721Phase 1Completed

Pharmacodynamic Study of Cilostazol in Healthy Volunteers

Started Aug 2015
77 enrolled
Healthy
NCT01995370Phase 4Completed

Cilostazol Stroke Prevention Study for Antiplatelet Combination

Started Dec 2013
1,884 enrolled
Noncardioembolic Cerebral Infarction
NCT02094469Phase 3Completed

Safety and Efficacy Study of Cilostazol to Treat Vasospastic Angina

Started Dec 2013
65 enrolled
Vasospastic Angina